The manufacturing enterprise "Akademfarm" offers consumers an antiviral drug "Duovir" for systemic use in the treatment of HIV infection under a manufacturing agreement and is looking for partners to conclude a distribution services agreement.

The group of medications known as systemic antiviral agents for the treatment of HIV infection is internationally referred to as antiretroviral drugs (ARVs). The global market for these medications is clearly divided into two groups: developers of original, innovative regimens (US and Europe) and the largest manufacturers of affordable generics (India). These corporations control over 75% of global sales by value. They create innovative all-in-one pills and extended-release injectable formulations:

1. Gilead Sciences (US) is the absolute global leader (controlling the majority of the market). It produces bestsellers such as Biktarvy, Genvoya, Truvada, as well as the revolutionary subcutaneous drug Lenacapavir (Yeztugo).
2. ViiV Healthcare (UK) is a specialized company created by GlaxoSmithKline (GSK) and Pfizer. Known for its drugs Tivicay (dolutegravir), Triumeq, Dovato, and the first long-acting injectable solution, Cabenuva.
3. Merck & Co. / MSD (USA) — produces the popular drugs Isentress (raltegravir) and Pifeltro (doravirine). It is actively collaborating with Gilead on the development of next-generation combination regimens.
4. Janssen Pharmaceuticals (part of Johnson & Johnson, USA) — a key manufacturer of protease inhibitors and other ART components, including Prezista (darunavir) and Edurant (rilpivirine).

Indian companies produce the bulk of medications for low- and middle-income countries, supplying them under WHO and UNAIDS programs:

1. Cipla Limited — a pioneer in affordable therapy, supplying combination ARVs worldwide.
2. Hetero Drugs is the largest supplier of finished dosage forms and active pharmaceutical ingredients for the treatment of HIV.

Information about the drug "Duovir", produced by the Enterprise "Akadempharm" - an antiviral agent for systemic use in the treatment of HIV infection as part of combination antiretroviral therapy, is posted on the official website of the Enterprise here.

In-house production. Highly qualified personnel.

International nonproprietary name: Lamivudine/Zidovudine.

Substance: India

* In other regions, packaging design may vary depending on the country of registration.

The Republican production unitary enterprise "ACADEMPHARM" is a dynamically developing, science-intensive state-owned pharmaceutical company. Despite its young age in the pharmaceutical industry, "ACADEMPHARM" has already carved out a niche in the domestic market and continues to expand. The company focuses on unmet medical needs, expanding its product range annually.

Activities:
- Laboratory pharmaceutical research;
- Industrial production of medicinal products and other pharmaceuticals, vitamins, vitamin-mineral and metabolic complexes, and nutraceuticals;
- Contract pharmaceutical manufacturing.

Production lines are equipped with the latest equipment from leading global companies, meeting all GMP requirements.

The pharmaceutical quality system includes good manufacturing practices, quality control, and quality risk management. It is fully documented, and its effectiveness is monitored. All components of the quality system are staffed with competent personnel, sufficient facilities, equipment, and technical resources.

Official website of the Enterprise "Academpharm".

The Republican production unitary enterprise "AKADEMPHARM" holds national GMP (Good Manufacturing Practice) certificates for the production of all forms of its own products.

The company has implemented and operates a pharmaceutical quality system developed in accordance with the requirements of the national standard TKP 030-2017 (33050) "Good Manufacturing Practice" and international requirements.

Consumers interested in purchasing a dosage of the antiviral drug "Duovir" for systemic use in the treatment of HIV infection may differ depending on the country of registration under a manufacturing agreement.

Partners interested in purchasing a dosage of the antiviral drug "Duovir" for systemic use in the treatment of HIV infection may differ depending on the country of registration under a distribution services agreement.